April 2022
Transcell Biologics is an adult stem cell technology investing group with biobanking – preserving both biosample and derived data, Hemato personalizing transplantation procedures, NeuroSAFE for testing the safety of vaccines and drugs like developed applications in practice working through both B2C and B2B engagement models.
Through this engagement with MitKat team, Transcell proactively aims to improve its group’s data handling, and storage procedures to achieve a regulatory and compliance position in the industry.
MitKat services are backed by experienced cyber-risk advisory and assurance teams which very well understands the needs of a growing company, says Pawan Desai, CEO, MitKat Advisory. In current times, the threat is prominent and real to all sizes or organization and even more so to companies which are growing rapidly, as they are always in a state of change and that creates vulnerabilities, which are exploited and can have catastrophic impact if timely action is not taken. Proving Data assurance helps organization in long way to build organizational resilience and client’s confidence, Pawan adds.
It’s no longer just about our own operational sops, intellectual property related data points security, it is an opportunity for us to demonstrate our commitment and long term intent, our preparedness to respective client’s concerns, says Dr.S.Dravida, Founder CEO of Transcell while engaging Mitkat.
MitKat Advisory is Singapore based Risk consultancy providing comprehensive security and risk management support across APAC. They work collaboratively with clients to de-risk their businesses. Their clients include the world’s most respected organizations.
No Comments
Sorry, the comment form is closed at this time.